Premium
KraneShares Artificial Intelligence ETF (AGIX)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting:...
DALLAS, June 19 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today. Investors can view all of the daily trading notes for free by...
CHICAGO, Jan. 31 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
AtheroGenics, Inc. (Nasdaq:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief...
Invitrogen and Leap Wireless Secure Top 100 Rankings SAN DIEGO, Aug. 2 /PRNewswire/ -- Mentus, a San Diego-based integrated marketing communications and design agency, announced today that the...
AtheroGenics Inc (NASDAQ: AGIX) announces the following Webcast: ? What: AtheroGenics Inc Second Quarter 2006 Earnings Conference Call Webcast ? When: July 20, 2006 @ 09:00 AM Eastern ? Where:...
AtheroGenics Inc (NASDAQ: AGIX) announces the following Webcast: ? What: AtheroGenics Inc First Quarter 2006 Earnings Conference Call Webcast ? When: April 20, 2006 @ 09:00 AM Eastern ? Where:...
ATLANTA, March 28 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today announced that Walker...
ATLANTA, March 2 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M...
ATLANTA, Feb. 28 /PRNewswire-FirstCall/ -- AtheroGenics, Inc. (NASDAQ:AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today reported financial results...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2101 | 0.707526519616 | 29.695 | 30.67 | 28.94 | 36116 | 29.62052948 | SP |
| 4 | 0.8951 | 3.08548776284 | 29.01 | 30.67 | 27.9 | 18841 | 29.25165063 | SP |
| 12 | 3.9251 | 15.1081601232 | 25.98 | 30.67 | 25.98 | 11353 | 29.10197834 | SP |
| 26 | 5.6651 | 23.3708745875 | 24.24 | 30.67 | 21.82 | 7194 | 27.70287285 | SP |
| 52 | 4.5451 | 17.922318612 | 25.36 | 30.67 | 21.82 | 7461 | 27.4279406 | SP |
| 156 | 4.5451 | 17.922318612 | 25.36 | 30.67 | 21.82 | 7461 | 27.4279406 | SP |
| 260 | 4.5451 | 17.922318612 | 25.36 | 30.67 | 21.82 | 7461 | 27.4279406 | SP |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
